In breast cancer, patients carrying mutations in the checkpoint kinase-2 (CHEK2) gene, which is a moderate penetrance breast cancer risk gene, 34 out of 144 elevated genes were OR genes16. Here, CHEK2 is linked to breast carcinoma.